Skip to main content
. 2012 Nov 28;54(1):145–153. doi: 10.3349/ymj.2013.54.1.145

Fig. 3.

Fig. 3

The cumulative survival rates according to RA type in patients with RA. The median survival of patients with diuretic-resistant type RA is significantly better than those with diuretic-intractable type RA [median 13.9 months (range, 4.1-51.3) vs. 5.6 months (range, 3.9-8.7); log-rank test, p=0.002]. RA, refractory ascites.